Synthesis and anti-tumor activity of cyclodepsipeptides paecilodepsipeptide A | |
Yang, Mingjun1,2; Wang, Yonggang2; Liu, Xiaofeng2; Wu, Jing2 | |
2013 | |
会议日期 | December 22, 2012 - December 23, 2012 |
会议地点 | Yichang, China |
关键词 | Cell culture Mass spectrometry Nanotechnology 1H NMR and 13C NMR spectra Anti-tumor activities Anti-tumors Antitumor drugs Cyclodepsipeptides Hepatocellular carcinoma cell Lymphoma cells Natural products Paecilodepsipeptide A Retrosynthesis Total synthesis |
卷号 | 643 |
DOI | 10.4028/www.scientific.net/AMR.643.92 |
页码 | 92-96 |
英文摘要 | Paecilodepsipeptide A was first synthesized by retrosynthesis methods. the structures were determined by Mass Spectrometry and NMR spectroscopy, and the anti-tumor activities on human hepatocellular carcinoma cell line (SMMC-7721) and human lymphoma cell line (Raji) were examined by MTT. The result showed that the rate of Paecilodepsipeptide A was 72% by retrosynthesis methods. The structures of the synthesized product were identified by 1H NMR and 13C NMR spectra, which is identical to the natural product. The product has remarkable anti-proliferation activity on SMMC-7721 and Raji, which showed good anti-tumor activity. IC50 was 8.97 μmol/L and 11.13 μmol/L respectively, The total synthesis of Paecilodepsipeptide A is significant to further study its derivatives and develop novel antitumor drugs. © (2013) Trans Tech Publications, Switzerland. |
会议录 | Advanced Materials Research |
会议录出版者 | Trans Tech Publications, P.O. Box 1254, Clausthal-Zellerfeld, D-38670, Germany |
语种 | 英语 |
ISSN号 | 10226680 |
内容类型 | 会议论文 |
源URL | [http://ir.lut.edu.cn/handle/2XXMBERH/117744] |
专题 | 生命科学与工程学院 |
作者单位 | 1.Lanzhou Jinchuan New Materials Co., Ltd., Lanzhou, China 2.Lanzhou University of Technology, Lanzhou, China; |
推荐引用方式 GB/T 7714 | Yang, Mingjun,Wang, Yonggang,Liu, Xiaofeng,et al. Synthesis and anti-tumor activity of cyclodepsipeptides paecilodepsipeptide A[C]. 见:. Yichang, China. December 22, 2012 - December 23, 2012. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论